Generic drugs the pay-for-delay problem /

The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
I whakaputaina: (1983)

Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
mā: Osmane, Malik
I whakaputaina: (2014)

Driving down the cost of drugs : battling big pharma in the statehouse /
mā: Castellblanch, Ram�on, 1948-
I whakaputaina: (2012)

Pharmaceutical economics and policy
mā: Schweitzer, Stuart O.
I whakaputaina: (2007)

Marketing Strategies Adopted by Generic and Original Drugs Manufacturing Companies in An Effort to Attain Strategic Competitiveness: A Study of Mombasa
mā: Mueni, Matingi Ireen
I whakaputaina: (2024)

The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
I whakaputaina: (2003)

Profits before people? ethical standards and the marketing of prescription drugs /
mā: Weber, Leonard J., 1942-
I whakaputaina: (2006)

CAPA for the FDA-regulated industry /
mā: Rodríguez Pérez, José, 1961-
I whakaputaina: (2010)

The risks of prescription drugs
I whakaputaina: (2010)

ADME-enabling technologies for drug design and development
I whakaputaina: (2012)

Drug discovery and design medical aspects /
I whakaputaina: (2002)

Drugs : from discovery to approval /
mā: Ng, Rick
I whakaputaina: (2015)

Drug discovery practices, processes, and perspectives /
I whakaputaina: (2013)

The art of drug synthesis
I whakaputaina: (2007)

Modern drug synthesis
I whakaputaina: (2010)

Successful drug discovery.
I whakaputaina: (2015)

Chemical drug design /
I whakaputaina: (2016)

Towards drugs of the future key issues in lead finding and lead optimization /
I whakaputaina: (2008)

Drug repositioning bringing new life to shelved assets and existing drugs /
I whakaputaina: (2012)

Frontiers in drug design and discovery.
I whakaputaina: (2010)

Drug-like properties concepts, structure design and methods : from ADME to toxicity optimization /
mā: Kerns, Edward Harvel
I whakaputaina: (2008)

Drug delivery strategies for poorly water-soluble drugs
I whakaputaina: (2012)

Pharmaceutical industry innovation and developments /
I whakaputaina: (2011)

Pharmaceutical blending and mixing /
I whakaputaina: (2015)

Drug delivery principles and applications /
mā: Wang, Binghe
I whakaputaina: (2005)

Drug delivery : principles and applications /
I whakaputaina: (2016)

Case studies in modern drug discovery and development
I whakaputaina: (2012)

Therapeutic targets modulation, inhibition, and activation /
I whakaputaina: (2012)

The agile approach to adaptive research optimizing efficiency in clinical development /
mā: Rosenberg, Michael J.
I whakaputaina: (2010)

Manufacturing of pharmaceutical proteins : from technology to economy /
mā: Behme, Stefan
I whakaputaina: (2015)

Advanced drug delivery /
I whakaputaina: (2013)

How to develop and implement a national drug policy
I whakaputaina: (2001)

Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
I whakaputaina: (2012)

Effective drug regulation a multicountry study /
mā: Ratanawijitrasin, Sauwakon
I whakaputaina: (2002)

The future of drug safety promoting and protecting the health of the public /
I whakaputaina: (2007)

Outsourcing clinical development strategies for working with CROs and other partners /
I whakaputaina: (2006)